This report contains market size and forecasts of Gefitinib in global, including the following market information:
Global Gefitinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gefitinib Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Gefitinib companies in 2021 (%)
The global Gefitinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10 Tables/Box Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gefitinib include AstraZeneca, Qilu Pharmaceutical, Natco Pharma, Celon Laboratories, Hetero Drugs, Dr Reddy's Laboratories, Zuventus Healthcare, United Biotech and Panacea Biotec, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gefitinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gefitinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gefitinib Market Segment Percentages, by Type, 2021 (%)
10 Tables/Box
30 Tables/Box
90 Tables/Box
Global Gefitinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gefitinib Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Drug Center
Other
Global Gefitinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gefitinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gefitinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gefitinib revenues share in global market, 2021 (%)
Key companies Gefitinib sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Gefitinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Qilu Pharmaceutical
Natco Pharma
Celon Laboratories
Hetero Drugs
Dr Reddy's Laboratories
Zuventus Healthcare
United Biotech
Panacea Biotec
Cipla
Glenmark Pharmaceuticals
Nobel Ilac Sanayii Ve Ticaret
Accure Labs
Cadila Pharmaceuticals
Ethypharm
Flagship Biotech International
Globela Pharma
Jodas Expoim
Nishchay Pharmaceuticals
Sichuan Xieli Pharmaceutical